Načítá se...

MEK blockade overcomes the limited activity of palbociclib in head and neck cancer

Head and neck cancer (HNC) is characterized with multiple aberrations in cell cycle pathways, including amplification of cyclin D1. Palbociclib (PAL), a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, has been reported to regulate cell cycle progression in HNC. However, recent studies have revealed...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Oncol
Hlavní autoři: Fang, Zhenghuan, Jung, Kyung Hee, Lee, Ji Eun, Cho, Jinhyun, Lim, Joo Han, Hong, Soon-Sun
Médium: Artigo
Jazyk:Inglês
Vydáno: Neoplasia Press 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7385517/
https://ncbi.nlm.nih.gov/pubmed/32712554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100833
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!